- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 07-09-2020Background: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. It is important to identify patients in whom…
- 07-09-2020Background: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. It is important to identify patients in whom…
- 07-09-2020Background: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. It is important to identify patients in whom…
- 01-09-2020BackgroundTrans women can be treated with hormone therapy to induce feminization such as more adipose tissue on the hips, softer…
- 01-09-2020BackgroundTrans women can be treated with hormone therapy to induce feminization such as more adipose tissue on the hips, softer…
